These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9260793)

  • 41. A 39-year-old man with chronic hepatitis, elevated serum ferritin values, and a family history of hemochromatosis.
    Bacon BR; Fried MW; DiBisceglie AM
    Semin Liver Dis; 1993 Feb; 13(1):101-5. PubMed ID: 8446904
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Iron overload in allogeneic hematopoietic stem cell transplant recipients.
    Ali S; Pimentel JD; Munoz J; Shah V; McKinnon R; Divine G; Janakiraman N
    Arch Pathol Lab Med; 2012 May; 136(5):532-8. PubMed ID: 22540302
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Iron overload in patients with chronic hepatitis C: a clinicopathologic study.
    Haque S; Chandra B; Gerber MA; Lok AS
    Hum Pathol; 1996 Dec; 27(12):1277-81. PubMed ID: 8958298
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Validation of serum ferritin values by magnetic susceptometry in predicting iron overload in dialysis patients.
    Canavese C; Bergamo D; Ciccone G; Longo F; Fop F; Thea A; Martina G; Piga A
    Kidney Int; 2004 Mar; 65(3):1091-8. PubMed ID: 14871430
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Alterations in iron metabolism in chronic anti-HCV positive hepatitis. The relationship with response to interferon treatment].
    López Morante A; Sáez-Royuela F; Echevarría C; Llanos C; Martín Lorente JL; Yuguero del Moral L; Ojeda Giménez C
    Gastroenterol Hepatol; 1995 Apr; 18(4):165-8. PubMed ID: 16541561
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Iron overload and glucose abnormalities in chronic hepatitis C virus infection: phlebotomy lowers risk of new-onset diabetes.
    Mifuji-Moroka R; Iwasa M; Miyachi H; Sugimoto R; Tanaka H; Ishihara T; Fujita N; Kaito M; Kobayashi Y; Takei Y
    Hepatogastroenterology; 2013 Oct; 60(127):1736-41. PubMed ID: 24634944
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of iron load on fibrogenesis in chronic hepatitis C.
    Casaril M; Stanzial AM; Tognella P; Pantalena M; Capra F; Colombari R; Corrocher R
    Hepatogastroenterology; 2000; 47(31):220-5. PubMed ID: 10690612
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Estimating iron overload in patients with suspected liver disease and elevated serum ferritin.
    Cippà PE; Boucsein I; Adams H; Krayenbuehl PA
    Am J Med; 2014 Oct; 127(10):1011.e1-3. PubMed ID: 24662623
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of translation initiation factors might be the potential therapeutic targets for HCV patients with hepatic iron overload.
    Liu Y; An D; Sun R; Jin L; Wang Q
    Med Hypotheses; 2012 Jan; 78(1):142-3. PubMed ID: 22047986
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The relationship between RBC ferritin content in chronic liver diseases and iron deposition in hepatocytes].
    Mae H
    Hokkaido Igaku Zasshi; 1994 Sep; 69(5):1244-51. PubMed ID: 7868062
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C.
    Olynyk JK; Reddy KR; Di Bisceglie AM; Jeffers LJ; Parker TI; Radick JL; Schiff ER; Bacon BR
    Gastroenterology; 1995 Apr; 108(4):1104-9. PubMed ID: 7698578
    [TBL] [Abstract][Full Text] [Related]  

  • 52. gamma-Glutamyl transpeptidase as a response predictor when using alpha-interferon to treat hepatitis C.
    Van Thiel DH; Friedlander L; Malloy P; Wright HI; Gurakar A; Fagiuoli S; Irish W
    Hepatogastroenterology; 1995; 42(6):888-92. PubMed ID: 8847041
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Uric acid as a potential cue to screen for iron overload.
    Mainous AG; Knoll ME; Everett CJ; Matheson EM; Hulihan MM; Grant AM
    J Am Board Fam Med; 2011; 24(4):415-21. PubMed ID: 21737766
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of iron overload on the response to recombinant interferon-alfa treatment in transfusion-dependent patients with thalassemia major and chronic hepatitis C.
    Clemente MG; Congia M; Lai ME; Lilliu F; Lampis R; Frau F; Frau MR; Faa G; Diana G; Dessì C
    J Pediatr; 1994 Jul; 125(1):123-8. PubMed ID: 8021761
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Measurements of iron status in patients with chronic hepatitis.
    Di Bisceglie AM; Axiotis CA; Hoofnagle JH; Bacon BR
    Gastroenterology; 1992 Jun; 102(6):2108-13. PubMed ID: 1587431
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A comparison between two induction regimes for the interferon treatment of chronic hepatitis C. Response related factors.
    Pérez R; Pravia R; Artímez ML; Linares A; Lombraña JL; Pérez-López R; Rodrigo L; San Miguel G; Pons F; Suárez F; Caro-Patón A
    Rev Esp Enferm Dig; 1997 Mar; 89(3):159-73. PubMed ID: 9141898
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum ferritin in Nigerian patients with amoebic liver abscess and other tropical infections with liver involvement.
    Bolarin DM
    Acta Trop; 1983 Jun; 40(2):159-64. PubMed ID: 6136177
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hyperferritinemia in a kidney transplant recipient.
    Furić-Cunko V; Basić-Jukić N; Jurić I; Kes P
    Acta Clin Croat; 2011 Jun; 50(2):245-8. PubMed ID: 22263390
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Insulin resistance and iron perturbation in patients with chronic hepatitis C.
    Mascitelli L; Pezzetta F; Goldstein MR
    Intern Med J; 2010 Feb; 40(2):168-9. PubMed ID: 20446965
    [No Abstract]   [Full Text] [Related]  

  • 60. Response to interferon alpha therapy is influenced by the iron content of the liver.
    Van Thiel DH; Friedlander L; Fagiuoli S; Wright HI; Irish W; Gavaler JS
    J Hepatol; 1994 Mar; 20(3):410-5. PubMed ID: 8014455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.